The American Cancer Society awards Greg Wang, Assistant Professor of Biochemistry & Biophysics, a research scholar grant to study the role of PRC2 dysregulation in cancer.
The four-year, $792,000 grant from the American Cancer Society begins on July 1, 2016 and will support his project “Deciphering the role for dysregulation of PRC2, a crucial chromatin-modifying enzymatic complex in cells, in the development of human cancer.”
Dr. Wang is an Assistant Professor in the Department of Biochemistry and Biophysics and a member of UNC Lineberger Comprehensive Cancer Center. He completed a postdoctoral fellowship with David Allis in the laboratory of Chromatin Biology & Epigenetics at Rockefeller University in New York. He was awarded a Howard Temin ‘Pathway to Independence’ Award in Cancer Research from the National Cancer Institute to continue his independent research at UNC. Since coming to UNC, he has received several awards from the V Foundation, UNC’s Jefferson Pilot Award, American Society of Hematology, Sidney Kimmel Foundation, Gabrielle’s Angel Foundation for Cancer Research, and the Concern Foundation for Cancer Research.
Research in his lab emphasizes chromatin biology and epigenetics. His group focuses on mechanistic understandings of how chemical modifications of chromatin define distinct patterns of mammalian genomes, control gene expression, and regulate cell proliferation versus differentiation during development, and how their deregulations lead to human diseases such as cancer, developmental disorders, and aging.